| Drossapharm AG - Atorvastax-Drossapharm 20 mg, Filmtabletten | | 70323 | | 02 | | Atorvastax-Drossapharm 20 mg | | Filmtabletten | | C10AA05 | | Atorvastatin | | 03.09.2026 | | |
| | Composition | | atorvastatinum 20 mg ut atorvastatinum calcicum, cellulosum microcristallinum, calcii carbonas, maltosum, carmellosum natricum conexum corresp. natrium max. 0.81 mg, polysorbatum 80, magnesii aluminometasilicas, magnesii stearas, Überzug: hypromellosum, hydroxypropylcellulosum, triethylis citras, polysorbatum 80, E 171, pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Atorvastatin | 20 mg |
| | | | Inactive agents | | additional_information |
|---|
| Calcium Carbonate | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Magnesii Aluminometasilicas | | | | Magnesii Stearas | | | | Maltosum | | | | Polysorbatum 80 | | | | Polysorbatum 80 | | | | Pro Compresso Obducto | | | | Triethylis Citras | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 30 | | | B | | Yes | | 004 | 100 | | | B | | Yes |
|
|
